Related Concept Videos
Acne Infection
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Accessory Structures of the Skin: Hair Growth and Types
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Treatment of Ulcerative Colitis in IBD
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man.
Related Experiment Video
Updated: May 31, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Systemic treatment for alopecia areata.
1Skin and Laser Center Potsdam, Hair Clinic, Potsdam, Germany. ninaotberg@gmx.com
Alopecia areata affects 1.7% of the global population, with limited effective treatments for severe cases. This review examines side effects and relapse rates of systemic agents used for severe alopecia areata.
Area of Science:
- Dermatology
- Immunology
Background:
- Alopecia areata (AA) is an autoimmune condition affecting 1.7% of the global population.
- The etiology of AA remains largely unknown, and its clinical course is unpredictable.
- Current treatments for severe forms like multifocal AA, alopecia totalis, and alopecia universalis are insufficient.
Purpose of the Study:
- To review and discuss the side effects of systemic agents used in treating severe and rapidly progressive alopecia areata.
- To analyze the relapse rates associated with these systemic treatments for severe alopecia areata.
Main Methods:
- Literature review of systemic agents for severe alopecia areata.
- Analysis of reported side effect profiles.
- Evaluation of relapse data from clinical studies and case reports.
Main Results:
- Systemic agents show variable efficacy but are associated with significant side effects.
- Relapse rates are a considerable concern across different treatment modalities.
- Data on long-term outcomes and comparative effectiveness is limited.
Conclusions:
- Effective and well-tolerated treatments for severe alopecia areata are still needed.
- Careful patient selection and monitoring are crucial when using systemic agents.
- Further research is required to establish optimal therapeutic strategies for severe alopecia areata.
